Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils

Journal of Immunology

Volumn 160, Issue 8, 1998, Pages 4010-4017

  Okada, Shinji ^b   Hagan, John B ^b   Kato, Masahiko ^b   Bankers Fulbright, Jennifer L ^b   Hunt, Loren W ^b   Gleich, Gerald J ^b   Kita, Hirohito ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; CINCHOCAINE; CYTOKINE; DRUG ANALOG; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR; LIDOCAINE; OXYBUPROCAINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROCAINE; PROTEIN KINASE C ACTIVATOR; PROXYMETACAINE; SUPEROXIDE; TETRACAINE; THROMBOCYTE ACTIVATING FACTOR; TYROSINE;

ALLERGIC DISEASE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL;

APOPTOSIS; CELL SURVIVAL; DEXAMETHASONE; EOSINOPHILS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-3; INTERLEUKIN-5; LIDOCAINE; SUPEROXIDES;

EID: 0032522838     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Butterfield, J. H., K. M. Leiferman, and G. J. Gleich. 1995. Eosinophil-associated diseases. In Samter's Immunologic Diseases, Vol. 1. M. Frank, K. F. Austen, H. N. Clamen, and E. R. Unanue, eds. Little, Brown and Company, Boston, p. 501.
2. Kita, H., and G. J. Gleich. 1997. The eosinophil: structure and functions. In Allergy. A. P. Kaplan, ed. W. B. Saunders Company, Philadelphia, p. 148.
3. Gleich, G. J., H. Kita, and C. R. Adolphson. 1995. Eosinophils. In Samter's Immunologic Diseases, Vol. 1. M. Frank, K. F. Austen, H. N. Clamen, and E. R. Unanue, eds. Little, Brown and Company, Boston, p. 205.
4. Ohnishi, T. H. Kita, D. Weiler, S. Sur, J. B. Sedgwick, W. J. Calhoun, W. W. Busse, J. S. Abrams, and G. J. Gleich. 1993. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am. Rev. Respir. Dis. 147:901.
5. Elbon, C. L., D. B. Jacoby, and A. D. Fryer. 1995. Pretreatment with an antibody to interleukin-5 prevents loss of pulmonary M2 muscarinic receptor function in antigen-challenged guinea pigs. Am. J. Respir. Cell Mol. Biol. 12:320.
6. Van Oosterhout, A. J., A. R. Ladenius, H. F. Savelkoul, I. Van Ark, K. C. Delsman, and F. P. Nijkamp. 1993. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am. Rev. Respir. Dis. 147:548.
7. Yamaguchi, S., H. Nagai, H. Tanaka, M. Tsujimoto, and N. Tsuruoka. 1994. Time course study for antigen-induced airway hyperreactivity and the effect of soluble IL-5 receptor. Life Sci. 54:PL471.
8. Schleimer, R. P., and B. S. Bochner. 1994. The effects of glucocorticoids on human eosinophils. J. Allergy Clin. Immunol. 94:1202.
9. Guyre, P. M., M. T. Girard, P. M. Morganelli, and P. D. Manganiello. 1988. Glucocorticoid effects on the production and actions of immune cytokines. J. Steroid Biochem. 30:89.
10. Leung, D. Y., R. J. Martin, S. J. Szefler, E. R. Sher, S. Ying, A. B. Kay, and Q. Hamid. 1995. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J. Exp. Med. 181:33.
11. Lamas, A. M., O. G. Leon, and R. P. Schleimer. 1991. Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. J. Immunol 147:254.
12. Wallen, N., H. Kita, D. Weiler, and G. J. Gleich. 1991. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J. Immunol. 147:3490.
13. Nicolaizik, W. H., J. L. Marchant, M. A. Preece, and J. O. Warner. 1994. Endocrine and lung function in asthmatic children on inhaled corticosteroids. Am. J. Respir. Crit. Care Med. 150:624.
14. Phillip, M., M. Aviram, E. Leiberman, Z. Zadik, Y. Giat, J. Levy, and A. Tal. 1992. Integrated plasma cortisol concentration in children with asthma receiving long-term inhaled corticosteroids. Pediatr. Pulmonol. 12:84.
15. Toogood, J. H., B. Jennings, A. B. Hodsman, J. Baskerville, and L. J. Fraher. 1991. Effects of dose and dosing schedule of inhaled budesonide on bone turn-over. J. Allergy Clin. Immunol. 88:572.
16. Schwartz, H. J., F. C. Lowell, and J. C. Melby. 1968. Steroid resistance in bronchial asthma. Ann. Intern. Med. 69:493.
17. Poznansky, M. C., A. C. Gordon, I. W. Grant, and A. H. Wyllie. 1985. A cellular abnormality in glucocorticoid resistant asthma. Clin. Exp. Immunol. 61:1352.
18. Ohnishi, T., H. Kita, A. N. Mayeno, S. Okada, S. Sur, D. H. Broide, and G. J. Gleich. 1996. Lidocaine in bronchoalveolar lavage fluid (BALF) is an inhibitor of eosinophil-active cytokines. Clin. Exp. Immunol. 104:325.
19. Hunt, L. W., H. A. Swedlund, and G. J. Gleich. 1996. Effect of nebulized lidocaine on severe glucocorticoid-dependent asthma. Mayo Clin. Proc. 71:361.
20. Ide, M., D. Weiler, H. Kita, and G. J. Gleich. 1994. Ammonium chloride exposure inhibits cytokine-mediated eosinophil survival. J. Immunol. Methods 168: 187.
21. Dive, C., C. D. Gregory, D. J. Phipps, D. L. Evans, A. E. Milner, and A. H. Wyllie. 1992. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys. Acta 1133:275.
22. Sun, X. M., R. T. Snowden, D. N. Skilleter, D. Dinsdale, M. G. Ormerod, and G. M. Cohen. 1992. A flow-cytometric method for the separation and quantitation of normal and apoptotic thymocytes. Anal. Biochem. 204:351.
23. Smith, C. A., G. T. Williams, R. Kingston, E. J. Jenkinson, and J. J. Owen. 1989. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337:181.
24. Lopez, A. F., M. A. Vadas, J. M. Woodcock, S. E. Milton, A. Lewis, M. J. Elliott, D. Gillis, R. Ireland, E. Olwell, and L. S. Park. 1991. Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils. J. Biol. Chem. 266:24741.
25. Horie, S., G. J. Gleich, and H. Kita. 1996. Cytokines directly induce degranulation and superoxide production from human eosinophils. J. Allergy Clin. Immunol. 98:371.
26. Stern, M., L. Meagher, J. Savill, and C. Haslett. 1992. Apoptosis in human eosinophils: programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J. Immunol. 148:3543.
27. Lopez, A. F., M. J. Elliott, J. Woodcock, and M. A. Vadas. 1992. GM-CSF, IL-3 and IL-5: cross-competition on human haemopoietic cells. Immunol. Today 13: 495.
28. Meagher, L. C., J. M. Cousin, J. R. Seckl, and C. Haslett. 1996. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J. Immunol. 156:4422.
29. Chihara, J., J. Plumas, V. Gruart, J. Tavernier, L. Prin, A. Capron, and M. Capron. 1990. Characterization of a receptor for interleukin 5 on human eosinophils: variable expression and induction by granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 172:1347.
30. Rothenberg, M. E., J. Petersen, R. L. Stevens, D. S. Silberstein, D. T. McKenzie, K. F. Austen, and W. F. Owen, Jr. 1989. IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. J. Immunol. 143:2311.
31. Pazdrak, K., D. Schreiber, P. Forsythe, L. Justement, and R. Alam. 1995. The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway. J. Exp. Med. 181:1827.
32. Van der Bruggen, T., E. Caldenhoven, D. Kanters, P. Coffer, J. A. Raaijmakers, J. W. Lammers, and L. Koenderman. 1995. Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Stat 1 alpha. Blood 85:1442.
33. Pazdrak, K., S. Stafford, and R. Alam. 1995. The activation of the Jak-STAT 1 signaling pathway by IL-5 in eosinophils. J. Immunol. 155:397.
34. Yousefi, S., D. R. Green, K. Blaser, and H. U. Simon. 1994. Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc. Natl. Acad. Sci. USA 91:10868.
35. Jarvis, W. D., A. J. Turner, L. F. Povirk, R. S. Traylor, and S. Grant. 1994. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res. 54:1707.
36. Horie, S., and H. Kita. 1994. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor. J. Immunol. 152:5457.
37. De Jong, R. H. 1994. Local Anesthetics. Mosby-Year Book, St. Louis.
38. Goldstein, I. M., S. Lind, S. Hoffstein, and G. Weissmann. 1977. Influence of local anesthetics upon human polymorphonuclear leukocyte function in vitro: reduction of lysosomal enzyme release and superoxide anion production. J. Exp. Med. 146:483.
39. Haines, K. A., J. Reibman, P. E. Callegari, S. B. Abramson, M. R. Philips, and G. Weissmann. 1990. Cocaine and its derivatives blunt neutrophil functions without influencing phosphorylation of a 47-kilodalton component of the reduced nicotinamide-adenine dinucleotide phosphate oxidase. J. Immunol. 144:4757.
40. Hansel, T. T., I. J. De Vries, J. M. Carballido, R. K. Braun, N. Carballido-Perrig, S. Rihs, K. Blaser, and C. Walker. 1992. Induction and function of eosinophil intercellular adhesion molecule-1 and HLA-DR. J. Immunol. 149:2130.
41. Scoggan, K. A., A. W. Ford-Hutchinson, and D. W. Nicholson. 1995. Differential activation of leukotriene biosynthesis by granulocyte-macrophage colony-stimulating factor and interleukin-5 in an eosinophilic substrain of HL-60 cells. Blood 86:3507.
42. + channels by local anesthetics. Science 265:1724.
43. + antiporter in suppression of apoptosis by granulocyte macrophage colony-stimulating factor and interleukin-3. J. Biol. Chem. 267:9980.
44. Grinstein, S., D. Rotin, and M. J. Mason. 1989. Na+/H + exchange and growth factor-induced cytosolic pH change: role in cellular proliferation. Biochim. Biophys. Acta 988:73.
45. Schwartz, M. A., D. E. Ingber, M. Lawrence, T. A. Springer, and C. Lechene. 1991. Multiple integrins share the ability to induce elevation of intracellular pH. Exp. Cell Res. 195:533.
46. Koo, G. C., J. T. Blake, A. Talento, M. Nguyen, S. Lin, A. Sirotina, K. Shah, K. Mulvany, D. J. Hora, P. Cunningham, D. L. Wunderler, O. B. McManus, R. Slaughter, R. Bugianesi, J. Felix, M. Garcia, J. Williamson, G. Kaczorowski, N. H. Sigal, M. S. Springer, and W. Feeney. 1997. Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J. Immunol. 158: 5120.